Explore comprehensive CDMO services offered by Pharmacosmos, supporting end-to-end Anlaytical Testing, Drug Development and Manufacturing. Pharmacosmos enables faster, compliant, and scalable pharma innovation tailored to your needs.
Country: China, Denmark, Germany, Ireland, Norway, Sweden, U.S.A., United Kingdom
Description: Pharmacosmos is a privately held Danish pharmaceutical company founded in 1965 that specializes in developing and manufacturing carbohydrate-based treatments for iron deficiency and anemia. Headquartered in Holbaek, Denmark, the company has a global presence and its key products include the intravenous iron treatments Monofer/Monoferric and Cosmofer, as well as Uniferon for veterinary use. Pharmacosmos focuses on research and development to address unmet patient needs in iron metabolism and blood-related disorders.
